ALX Oncology Holdings Inc.
ALXO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $19 | $21 | $18 |
| Short-Term Investments | $37 | $60 | $77 | $110 |
| Receivables | $0 | $1 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $5 | $4 | $7 |
| Total Curr. Assets | $67 | $85 | $103 | $134 |
| Property Plant & Equip (Net) | $1 | $1 | $9 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $6 | $4 | $9 | $4 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $4 | $0 | $0 |
| Total NC Assets | $16 | $10 | $18 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $83 | $95 | $121 | $148 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $4 | $4 |
| Short-Term Debt | $4 | $5 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $17 | $9 | $13 | $14 |
| Total Curr. Liab. | $28 | $19 | $19 | $19 |
| LT Debt | $0 | $11 | $8 | $9 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $1 | $6 | $6 |
| Total NC Liab. | $10 | $12 | $14 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $6 | $0 | $0 |
| Total Liabilities | $38 | $31 | $33 | $34 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$700 | -$678 | -$652 | -$621 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $745 | $742 | $740 | $734 |
| Total Equity | $45 | $64 | $88 | $114 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $83 | $95 | $121 | $148 |
| Net Debt | -$19 | -$3 | -$11 | -$8 |